secwatch.observer — SEC 8-K summary
======================================

Issuer:     AVENUE THERAPEUTICS, INC. (ATXI)
CIK:        0001644963
Form:       8-K
Filed at:   2024-01-12T23:59:59+00:00
Accession:  0001104659-24-003470
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Avenue Therapeutics shareholders approve increase in authorized shares from 75M to 200M and warrant issuance
--------------------------------------------------------------------------------

- Written consent from holders of 56.4% voting power approved Authorized Share Increase to 200M shares.
- Issuance of warrants (Jan 5 inducement) exceeding 20% of outstanding common stock authorized.
- Authorized common stock increased from 75M to 200M shares via amendment to certificate of incorporation.
- Board also approved the share increase, share issuance, and amendment.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924003470/0001104659-24-003470-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1644963/000110465924003470/tm243128d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-24-003470

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer